Paper32003754
K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages.
Zhou Z and 7 others. Aging (Albany NY), 2020. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages. Papers, record 32003754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32003754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autophagy | Major topic |
| Inflammasomes | Major topic |
| Lipoproteins, LDL | Major topic |
| Macrophages | Major topic |
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Ubiquitin | Major topic |
| Cell Line, Tumor | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Protein Binding | |
| Proteolysis | |
| Ubiquitination |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22571369 | Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. | BioDrugs | 2012 | https://conductscience.org/library/papers/22571369 | PubMed |
| 2 | 20034776 | Mammalian autophagy: core molecular machinery and signaling regulation. | Curr Opin Cell Biol | 2010 | https://conductscience.org/library/papers/20034776 | PubMed |
| 3 | 8696938 | Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. | Arterioscler Thromb Vasc Biol | 1996 | https://conductscience.org/library/papers/8696938 | PubMed |
| 4 | 22895665 | Inflammation in atherosclerosis. | Arterioscler Thromb Vasc Biol | 2012 | https://conductscience.org/library/papers/22895665 | PubMed |
| 5 | 26437584 | Ubiquitin-Dependent And Independent Signals In Selective Autophagy. | Trends Cell Biol | 2016 | https://conductscience.org/library/papers/26437584 | PubMed |
| 6 | 27669650 | Mechanism and Regulation of NLRP3 Inflammasome Activation. | Trends Biochem Sci | 2016 | https://conductscience.org/library/papers/27669650 | PubMed |
| 7 | 27931771 | Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation. | Trends Endocrinol Metab | 2017 | https://conductscience.org/library/papers/27931771 | PubMed |
| 8 | 20428172 | NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. | Nature | 2010 | https://conductscience.org/library/papers/20428172 | PubMed |
| 9 | 29343546 | p62 filaments capture and present ubiquitinated cargos for autophagy. | EMBO J | 2018 | https://conductscience.org/library/papers/29343546 | PubMed |
| 10 | 20206555 | Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. | Immunity | 2010 | https://conductscience.org/library/papers/20206555 | PubMed |
| 11 | 22286270 | Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. | Nat Immunol | 2012 | https://conductscience.org/library/papers/22286270 | PubMed |
| 12 | 25607459 | A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. | Immunity | 2015 | https://conductscience.org/library/papers/25607459 | PubMed |
| 13 | 18490534 | Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. | Circulation | 2008 | https://conductscience.org/library/papers/18490534 | PubMed |
| 14 | 3276731 | Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3276731 | PubMed |
| 15 | 29773990 | Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29773990 | PubMed |
| 16 | 8690807 | Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8690807 | PubMed |
| 17 | 29507397 | Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. | Cell Res | 2018 | https://conductscience.org/library/papers/29507397 | PubMed |
| 18 | 12019269 | PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12019269 | PubMed |
| 19 | 20303873 | The inflammasomes. | Cell | 2010 | https://conductscience.org/library/papers/20303873 | PubMed |
| 20 | 2538923 | A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. | Science | 1989 | https://conductscience.org/library/papers/2538923 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42148064 | The regulatory mechanism of NLRP3 inflammasome in the "immune paralytic-overactivation" imbalance in sepsis: the latest progress from molecular signaling to clinical translation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148064 | PubMed |
| 42132201 | Hotspots Evolution and Cutting-Edge Trends: A Bibliometric Analysis of Autophagy in Myocardial Infarction Studies From 2007 to 2025. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42132201 | PubMed |
| 42115609 | Proteasome inhibition enhances lysosome-mediated targeted protein degradation. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42115609 | PubMed |
| 41057360 | E3 Ubiquitin ligases Cbl-b and c-Cbl maintain the homeostasis of macrophages by regulating the M-CSF/M-CSFR signaling axis. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41057360 | PubMed |
| 40842475 | From mitochondria to heart: the role and challenges of mitochondrial antiviral signaling protein in cardiovascular disease. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40842475 | PubMed |
| 40055311 | Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40055311 | PubMed |
| 39985286 | UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome Activation. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39985286 | PubMed |
| 39733202 | Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway. | J Cardiovasc Transl Res | 2025 | https://conductscience.org/library/papers/39733202 | PubMed |
| 39195255 | Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome. | Cells | 2024 | https://conductscience.org/library/papers/39195255 | PubMed |
| 39077721 | Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study. | Rev Cardiovasc Med | 2022 | https://conductscience.org/library/papers/39077721 | PubMed |
| 38630150 | FoxG1 as a Potential Therapeutic Target for Alzheimer's Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway. | Cell Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38630150 | PubMed |
| 38093299 | Host microbiome associated low intestinal acetate correlates with progressive NLRP3-dependent hepatic-immunotoxicity in early life microcystin-LR exposure. | BMC Pharmacol Toxicol | 2023 | https://conductscience.org/library/papers/38093299 | PubMed |
| 35960407 | Autophagy Balances Neuroinflammation in Alzheimer's Disease. | Cell Mol Neurobiol | 2023 | https://conductscience.org/library/papers/35960407 | PubMed |
| 35569818 | New insight into dyslipidemia-induced cellular senescence in atherosclerosis. | Biol Rev Camb Philos Soc | 2022 | https://conductscience.org/library/papers/35569818 | PubMed |
| 35145029 | TRIM14 inhibits OPTN-mediated autophagic degradation of KDM4D to epigenetically regulate inflammation. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35145029 | PubMed |
| 34512673 | The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3. | Front Immunol | 2021 | https://conductscience.org/library/papers/34512673 | PubMed |
| 34206503 | The Pathways Underlying the Multiple Roles of p62 in Inflammation and Cancer. | Biomedicines | 2021 | https://conductscience.org/library/papers/34206503 | PubMed |
| 33850310 | An update on the regulatory mechanisms of NLRP3 inflammasome activation. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33850310 | PubMed |
| 33505579 | Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33505579 | PubMed |
| 33364229 | Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay. | Front Chem | 2020 | https://conductscience.org/library/papers/33364229 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AIM2 | 9447 | PubTator's text mining | https://conductscience.org/library/genes/9447 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| MAP1LC3A | 84557 | PubTator's text mining | https://conductscience.org/library/genes/84557 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| NUP62 | 23636 | PubTator's text mining | https://conductscience.org/library/genes/23636 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| PYCARD | 29108 | PubTator's text mining | https://conductscience.org/library/genes/29108 | NCBI Gene |
| SQSTM1 | 8878 | PubTator's text mining | https://conductscience.org/library/genes/8878 | NCBI Gene |
| STAMBP | 10617 | PubTator's text mining | https://conductscience.org/library/genes/10617 | NCBI Gene |
| TPPP3 | 51673 | PubTator's text mining | https://conductscience.org/library/genes/51673 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32003754
GET https://conductscience.org/api/papers/v1/32003754/references?page=2